Fig. 5From: Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPDRatio of geometric means for CHF6001 to placebo for markers of inflammation in blood (Pharmacodynamic population). Data are the ratios of geometric means and 95% CI. *p < 0.05. Abbreviation: BID, twice daily. A total of 56 patients were included in the CHF6001 800 μg Pharmacodynamic population, 57 in the CHF6001 1600 μg population and 57 in the placebo populationBack to article page